WBR0089: Difference between revisions

Jump to navigation Jump to search
Ochuko Ajari (talk | contribs)
No edit summary
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Ochuko}}
|QuestionAuthor={{Ochuko}} (Reviewed by Will Gibson)
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Biochemistry, Genetics
|MainCategory=Biochemistry, Genetics
Line 20: Line 20:
|MainCategory=Biochemistry, Genetics
|MainCategory=Biochemistry, Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|Prompt=A 46- year old man was brought to the emergency department by his son with complaints of jerky movements, progressive loss of memory and aggressiveness. His symptoms started 2 years ago and have progressively worsened over the years. His father and grandfather died of similar symptoms. The deficiency of which of the following caused his symptoms?
|Prompt=A 46-year-old man is brought to the emergency department by his son for jerky movements, progressive loss of memory and aggressiveness. His symptoms began 2 years ago and have progressively worsened. The patient's father and grandfather died of similar symptoms. Deficiency of which of the following is most likely responsible for this patient's symptoms?
|Explanation=The patient in this vignette has Huntington’s disease.  It is caused by deficiencies in the neurotransmitters GABA and Ach. Symptoms manifest in affected individuals between the ages of 20 and 50. It is a trinucleotide repeat disorder (CAG)n with the gene located on chromosome 4. Findings include depression, progressive dementia, choreiform movements, caudate atrophy and decreased levels of GABA and Ach in the brain
|Explanation=The patient in this vignette has Huntington’s disease, a uniformly fatal neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline. Symptoms manifest in affected individuals between the ages of 20 and 50. Clinical findings include depression, progressive dementia, choreiform movements, caudate atrophy and decreased levels of both GABA and Acetylcholine in the brain. It is a trinucleotide repeat disorder caused by (CAG)n repeats in the Huntingtin gene located on chromosome 4.
 
Expansion of this CAG triplet repeat stretch within the Huntingtin gene results in a different (mutant) form of the protein that gradually damages cells in the brain through mechanisms that are not fully understood. The disease is inherited in an autosomal dominant manner and displays genetic [[anticipation]]. This anticipation is thought to be caused by polymerase "slippage" during DNA replication in germ cells, thereby increasing the length of the repeat segment.
Wiki-mnemomic: You hunt animals and put them in the '''CAG'''e: Huntington Disease is a '''CAG''' repeat disorder.
 
|AnswerA=Serotonin
|AnswerA=Serotonin
|AnswerAExp=Serotonin is decreased in anxiety, depression and increased in Parkinson’s disease
|AnswerAExp=[[Serotonin]] is decreased in anxiety, depression and increased in [[Parkinson’s disease]]
|AnswerB=GABA
|AnswerB=GABA
|AnswerBExp=GABA is a neurotransmitter deficient in Huntington disease. Also decreased is the neurotransmitter Ach
|AnswerBExp=Patients with Huntington's disease have a deficiency of the neurotransmitters [[GABA]] and acetylcholine.
|AnswerC=Dopamine
|AnswerC=Dopamine
|AnswerCExp=Dopamine is increased in schizophrenia, decreased in Parkinson’s disease and depression
|AnswerCExp=Dopamine is increased in schizophrenia, but decreased in Parkinson’s disease and depression.  It is not known to be altered in Huntington's disease.
|AnswerD=Glutamate
|AnswerD=Glutamate
|AnswerDExp=Glutamate is used by the brain to synthesize GABA but the deficiency of it does not cause Huntington disease. Neuronal death in Huntington disease is through NMDA-R binding and glutamate toxicity
|AnswerDExp=Glutamate is used by the brain to synthesize GABA but its  deficiency is not implicated in the pathogenesis of Huntington's disease. Instead, neurons are thought to undergo "excitotoxic death" in Huntington disease, whereby mutant huntingtin protein increases glutamatergic neurotransmission through NMDA receptors to neurotoxic levels.
|AnswerE=Norepinephrine
|AnswerE=Norepinephrine
|AnswerEExp=Norepinephrine is a neurotransmitter seen in anxiety where it is increased and in depression, it is decreased
|AnswerEExp=Norepinephrine is a neurotransmitter that is increased in anxiety and decreased in depression.
|EducationalObjectives=Huntington's disease is associated with a deficiency of GABA and acetylcholine in the brains of affected patients.
|References=First Aid 2014 page 454
|RightAnswer=B
|RightAnswer=B
|WBRKeyword=Brain, Neurodegenerative, Huntington disease, Huntington's disease, Genetics, Neurology, Neurotransmitter, Depression, GABA, Acetylcholine,
|Approved=Yes
|Approved=Yes
}}
}}

Revision as of 02:08, 21 March 2014

 
Author [[PageAuthor::Ogheneochuko Ajari, MB.BS, MS [1] (Reviewed by Will Gibson)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Biochemistry, MainCategory::Genetics
Sub Category SubCategory::Neurology
Prompt [[Prompt::A 46-year-old man is brought to the emergency department by his son for jerky movements, progressive loss of memory and aggressiveness. His symptoms began 2 years ago and have progressively worsened. The patient's father and grandfather died of similar symptoms. Deficiency of which of the following is most likely responsible for this patient's symptoms?]]
Answer A AnswerA::Serotonin
Answer A Explanation [[AnswerAExp::Serotonin is decreased in anxiety, depression and increased in Parkinson’s disease]]
Answer B AnswerB::GABA
Answer B Explanation [[AnswerBExp::Patients with Huntington's disease have a deficiency of the neurotransmitters GABA and acetylcholine.]]
Answer C AnswerC::Dopamine
Answer C Explanation AnswerCExp::Dopamine is increased in schizophrenia, but decreased in Parkinson’s disease and depression. It is not known to be altered in Huntington's disease.
Answer D AnswerD::Glutamate
Answer D Explanation [[AnswerDExp::Glutamate is used by the brain to synthesize GABA but its deficiency is not implicated in the pathogenesis of Huntington's disease. Instead, neurons are thought to undergo "excitotoxic death" in Huntington disease, whereby mutant huntingtin protein increases glutamatergic neurotransmission through NMDA receptors to neurotoxic levels.]]
Answer E AnswerE::Norepinephrine
Answer E Explanation AnswerEExp::Norepinephrine is a neurotransmitter that is increased in anxiety and decreased in depression.
Right Answer RightAnswer::B
Explanation [[Explanation::The patient in this vignette has Huntington’s disease, a uniformly fatal neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline. Symptoms manifest in affected individuals between the ages of 20 and 50. Clinical findings include depression, progressive dementia, choreiform movements, caudate atrophy and decreased levels of both GABA and Acetylcholine in the brain. It is a trinucleotide repeat disorder caused by (CAG)n repeats in the Huntingtin gene located on chromosome 4.

Expansion of this CAG triplet repeat stretch within the Huntingtin gene results in a different (mutant) form of the protein that gradually damages cells in the brain through mechanisms that are not fully understood. The disease is inherited in an autosomal dominant manner and displays genetic anticipation. This anticipation is thought to be caused by polymerase "slippage" during DNA replication in germ cells, thereby increasing the length of the repeat segment. Wiki-mnemomic: You hunt animals and put them in the CAGe: Huntington Disease is a CAG repeat disorder.
Educational Objective: Huntington's disease is associated with a deficiency of GABA and acetylcholine in the brains of affected patients.
References: First Aid 2014 page 454]]

Approved Approved::Yes
Keyword WBRKeyword::Brain, WBRKeyword::Neurodegenerative, WBRKeyword::Huntington disease, WBRKeyword::Huntington's disease, WBRKeyword::Genetics, WBRKeyword::Neurology, WBRKeyword::Neurotransmitter, WBRKeyword::Depression, WBRKeyword::GABA, WBRKeyword::Acetylcholine
Linked Question Linked::
Order in Linked Questions LinkedOrder::